Squire Patton Boggs has opened an office in Geneva, as part of a plan to expand its international dispute resolution practice.
18 July 2024
A Swiss tribunal has ruled on a Russian fertiliser producer’s claim against US Formula 1 racing team Haas over a sponsorship agreement that was terminated in the wake of Russia’s war on Ukraine.
26 June 2024
The Swiss Federal Supreme Court has upheld an award in favour of a Kosovan government-owned entity, which found that changes to its partnership agreement with a local distributor violated public procurement law.
18 June 2024
The Swiss Federal Supreme Court has rejected a challenge to an ICC award based on an arbitrator’s repeat appointments by Schellenberg Wittmer – observing that the “relatively small circle” of lawyers specialising in international arbitration means such contacts on their own don’t suggest bias.
13 June 2024
The Swiss Federal Supreme Court has upheld an Energy Charter Treaty award that ordered Spain to pay €29.6 million to France’s EDF, finding that the prohibition on intra-EU ECT arbitrations established in Komstroy was based on an erroneous reading of the treaty.
03 May 2024
An ICSID tribunal has found Colombia liable in a US$64.5 million claim by Glencore over access to a port facility – although the state says around 85% of the commodities trader’s damages claims were dismissed.
23 April 2024
Veijo Heiskanen has left Lalive after more than two decades to practise as an independent arbitrator and member of Arbitra International.
02 April 2024
An English judge has refused to allow the Czech Republic to amend its challenge to a US$730 million treaty award over a blood plasma business to introduce a new objection based on the multiple nationalities of one of the claimants.
28 March 2024
Clyde & Co is the latest law firm to announce it is preparing investment treaty claims against Switzerland on behalf of investors affected by the write-down of Credit Suisse bonds.
26 March 2024
A UK court has upheld one of the Czech Republic’s grounds of challenge to a US$730 million treaty award won by investors in a blood plasma business, while dismissing or reserving judgment on other objections.
08 March 2024
Unlock unlimited access to all Global Arbitration Review content